跳至主要内容
临床试验/NCT05913882
NCT05913882招募中不适用

Combined Respiratory Training to Improve Pulmonary and Cough Function in Persons With ALS

Nova Southeastern University1 个研究点 分布在 1 个国家目标入组 34 人开始时间: 2023年8月22日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
34
试验地点
1
主要终点
Peak Cough Flow

研究概览

简要总结

The goal of this interventional trial is to learn about lung volume recruitment (LVR) and expiratory muscle strength training (EMST) in a total of up to 39 patients diagnosed with ALS. The following aims will be addressed:

  1. Determine the impact of combined LVR and EMST on cough strength and respiratory function in individuals with ALS.
  2. Determine the impact of combined LVR and EMST on patient-reported dyspnea and bulbar impairment.
  3. Describe the effect of combined LVR and EMST on patient- and caregiver reported burden and quality of life.

详细描述

In this delayed start, repeated-measures design, pALS will serve as their own control to provide treatment to all participants and control for disease heterogeneity (i.e., interparticipant differences). Participation will include three in-person evaluations and four weekly telehealth therapy sessions (Figure 3). Weekly telehealth therapy sessions will include home peak cough flow assessment, LVR and EMST training sessions to ensure treatment fidelity, maximum phonation time as a surrogate measure of forced vital capacity, and patient-reported outcomes including the ALS Respiratory Symptom Scale. To assess peak cough flow at home, participants will be provided with a commercially available peak cough flow meter (MiniWright, PF100) for guided assessment during telehealth appointments.

Study Timeline.

Study assessments and procedures at each time point are briefly described below and depicted in Table 1.

Screening/Baseline 1 (Week -5).

Following consenting and screening procedures, study personnel will complete the initial baseline assessment procedures. Participants will complete the initial baseline assessment in approximately 60-90 minutes.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •A diagnosis of probable or definite ALS in accordance with the Revisited El-Escorial Criteria.
  • •Disease duration from symptom onset of ≤ 2 years,
  • •Lung volume recruitment and expiratory muscle strength training naïve,
  • •Reduced peak cough flow (% predicted for age and gender).

排除标准

  • •History of stroke, head and neck cancer or other concomitant disorder that might contribute to dysphagia or respiratory impairment.
  • •Use of prescription cough assist or non-invasive volume ventilation devices.
  • •Enrollment in another research investigation that might impact cough or respiratory function.
  • •Diagnosis of frontotemporal dementia or advanced cognitive impairment.
  • •Tracheostomy placement/Use of invasive mechanical ventilation.
  • •Contraindications for respiratory training (i.e., history of pneumothorax, severe chronic obstructive pulmonary disease).

研究组 & 干预措施

Lung Volume Recruitment +Expiratory Muscle Strength Training

Experimental

All enrolled participants will commence a combined lung volume recruitment and expiratory muscle strength training exercise regimen following a 5-week no-intervention lead-in period.

干预措施: Respiratory Muscle Strength Training (LVR+EMST) (Device)

结局指标

主要结局

Peak Cough Flow

时间窗: From Baseline 1 to Final Evaluation (10 weeks)

Greatest cough measurement measured in liters/minute.

次要结局

  • Pulmonary Function Assessment(From Baseline 1 to Final evaluation (10 weeks))
  • Cough Spirometry(From Baseline 2 to Final Evaluation (5 weeks))
  • Pulmonary Function Assessment(From Baseline 1 to Final Evaluation (10 weeks))

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Lauren Tabor Gray, PhD

Principal Investigator

Nova Southeastern University

研究点 (1)

Loading locations...

相似试验